These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11256426)

  • 21. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation.
    Duquesnoy RJ
    Curr Opin Immunol; 2008 Oct; 20(5):594-601. PubMed ID: 18655832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients.
    Heidt S; Witvliet MD; Haasnoot GW; Claas FH
    Transpl Immunol; 2015 Oct; 33(2):51-7. PubMed ID: 26325207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The predictive value of epitope analysis in highly sensitized patients awaiting renal transplantation.
    Laundy GJ; Bradley BA
    Transplantation; 1995 Apr; 59(8):1207-13. PubMed ID: 7537397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
    Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
    Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
    Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
    Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients.
    Valentini RP; Nehlsen-Cannarella SL; Gruber SA; Mattoo TK; West MS; Lang C; Imam AA
    Pediatr Transplant; 2007 Feb; 11(1):77-81. PubMed ID: 17239127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.
    Heidt S; Haasnoot GW; Witvliet MD; van der Linden-van Oevelen MJH; Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Otten HG; Roelen DL; Claas FHJ
    Am J Transplant; 2019 Oct; 19(10):2926-2933. PubMed ID: 31155833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies.
    Glotz D; Antoine C; Julia P; Pegaz-Fiornet B; Duboust A; Boudjeltia S; Fraoui R; Combes M; Bariety J
    Transpl Int; 2004 Jan; 17(1):1-8. PubMed ID: 14685653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.
    Heidt S; Haasnoot GW; Claas FHJ
    Curr Opin Organ Transplant; 2018 Aug; 23(4):493-499. PubMed ID: 29846197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The virtual crossmatch--a screening tool for sensitized pediatric heart transplant recipients.
    Zangwill SD; Ellis TM; Zlotocha J; Jaquiss RD; Tweddell JS; Mussatto KA; Berger S
    Pediatr Transplant; 2006 Feb; 10(1):38-41. PubMed ID: 16499585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donor.
    Mumford L; Fuggle SV; Martorell J; Slavcev A; Iniotaki A; Haasnoot GW; Heidt S; Claas FHJ
    Transpl Immunol; 2021 Feb; 64():101354. PubMed ID: 33276060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Desensitization protocols in immunized living donor kidney transplant recipients].
    Nocera A
    G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crossmatch prediction of highly sensitized patients.
    Clark BD; Leong SW
    Clin Transpl; 1992; ():435-55. PubMed ID: 1306717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloantibody and xenoantibody cross-reactivity in transplantation.
    Cooper DK; Tseng YL; Saidman SL
    Transplantation; 2004 Jan; 77(1):1-5. PubMed ID: 14724427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The changing role of antibody testing in transplantation.
    Leffell MS; Montgomery RA; Zachary AA
    Clin Transpl; 2005; ():259-71. PubMed ID: 17424745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histocompatibility tests in a transplantation program].
    de-Leo-Cervantes C
    Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.